Company profile
Heron Therapeutics, Inc. /de/ Insider Trading
HRTXEvery SEC Form 4 insider trading filing for Heron Therapeutics, Inc. /de/ (HRTX) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0000818033
- Filings
- 119
- Insiders
- 17
- Last filing
- 2026-08-06
Activity summary
Recent insider activity is bullish. Over the last 30 days, 16 insiders purchased shares versus 5 sales. Buying was led by Hensley Mark Earl.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Heron Therapeutics, Inc. /de/ insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $8.7M.
90 day insight
Over the last 90 days, Heron Therapeutics, Inc. /de/ insiders bought $0 (26 transactions) and sold $14K (8 transactions).
- Most active insider: Duarte Ira with 12 transactions totaling $5K.
- Largest single sale: $4K by Hensley Mark Earl on Aug 6, 2026.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Hensley Mark Earl | HRTX | Tax Withholding | 8,888 | $0.50 | $4K |
| Aug 6, 2026 | Hensley Mark Earl | HRTX | Option Exercise | 31,250 | — | — |
| Aug 6, 2026 | Hensley Mark Earl | HRTX | Option Exercise | 31,250 | — | — |
| Jul 31, 2026 | Hensley Mark Earl | HRTX | Option Exercise | 11,769 | — | — |
| Jul 31, 2026 | Duarte Ira | HRTX | Option Exercise | 11,694 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=HRTX" \
-H "X-Api-Key: $KEY"Get a keyTop insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Heron Therapeutics, Inc. /de/ as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →